Wespac Advisors So Cal, LLC Bluebird Bio, Inc. Transaction History

Wespac Advisors So Cal, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 30, 2019	SELL	$75.84 - $105.21 $13,272 - $18,411	-175 Closed	0 $0
Q3 2018 Oct 22, 2018	BUY	$88.86 - $117.49 $15,550 - $20,560	175 New	175 $25,000
Q2 2018 Jul 13, 2018	SELL	$99.64 - $127.59 $17,437 - $22,328	-175 Closed	0 $0
Q1 2018 Apr 16, 2018	SELL	$105.8 - $150.94 $21,160 - $30,188	-200 Reduced 53.33%	175 $29,000
Q4 2017 Feb 13, 2018	SELL	$81.25 - $130.7 $10,156 - $16,337	-125 Reduced 25.0%	375 $66,000
Q3 2017 Nov 03, 2017	BUY	$57.74 - $91.42 $28,870 - $45,710	500	500 $68,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Wespac Advisors So Cal, LLC, based on Form 13F filings with the SEC.

Stay updated on Wespac Advisors So Cal, LLC with notifications on news.